Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model

Laura Higginbotham, Dave Mathews, Cynthia A. Breeden, Mingqing Song, Alton Brad Farris, Christian P. Larsen, Mandy L. Ford, Andrew J. Lutz, Matthew Tector, Kenneth A. Newell, A. Joseph Tector, Andrew B. Adams

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Xenotransplantation has the potential to alleviate the organ shortage that prevents many patients with end-stage renal disease from enjoying the benefits of kidney transplantation. Despite significant advances in other models, pig-to-primate kidney xenotransplantation has met limited success. Preformed anti-pig antibodies are an important component of the xenogeneic immune response. To address this, we screened a cohort of 34 rhesus macaques for anti-pig antibody levels. We then selected animals with both low and high titers of anti-pig antibodies to proceed with kidney transplant from galactose-α1,3-galactose knockout/CD55 transgenic pig donors. All animals received T-cell depletion followed by maintenance therapy with costimulation blockade (either anti-CD154 mAb or belatacept), mycophenolate mofetil, and steroid. The animal with the high titer of anti-pig antibody rejected the kidney xenograft within the first week. Low-titer animals treated with anti-CD154 antibody, but not belatacept exhibited prolonged kidney xenograft survival (>133 and >126 vs. 14 and 21 days, respectively). Long-term surviving animals treated with the anti-CD154-based regimen continue to have normal kidney function and preserved renal architecture without evidence of rejection on biopsies sampled at day 100. This description of the longest reported survival of pig-to-non-human primate kidney xenotransplantation, now >125 days, provides promise for further study and potential clinical translation.

Original languageEnglish
Pages (from-to)221-230
Number of pages10
JournalXenotransplantation
Volume22
Issue number3
DOIs
StatePublished - May 1 2015

Fingerprint

Heterografts
Primates
Anti-Idiotypic Antibodies
Swine
Transplants
Kidney
Heterologous Transplantation
Galactose
Mycophenolic Acid
Macaca mulatta
Kidney Transplantation
Chronic Kidney Failure
Steroids
Tissue Donors
T-Lymphocytes
Biopsy

Keywords

  • costimulation blockade
  • human decay-accelerating factor
  • non-human primate
  • renal transplantation
  • transgenic pigs
  • xenoantigen
  • xenotransplantation
  • α-1,3-galactosyltransferase

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model. / Higginbotham, Laura; Mathews, Dave; Breeden, Cynthia A.; Song, Mingqing; Farris, Alton Brad; Larsen, Christian P.; Ford, Mandy L.; Lutz, Andrew J.; Tector, Matthew; Newell, Kenneth A.; Tector, A. Joseph; Adams, Andrew B.

In: Xenotransplantation, Vol. 22, No. 3, 01.05.2015, p. 221-230.

Research output: Contribution to journalArticle

Higginbotham, L, Mathews, D, Breeden, CA, Song, M, Farris, AB, Larsen, CP, Ford, ML, Lutz, AJ, Tector, M, Newell, KA, Tector, AJ & Adams, AB 2015, 'Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model', Xenotransplantation, vol. 22, no. 3, pp. 221-230. https://doi.org/10.1111/xen.12166
Higginbotham, Laura ; Mathews, Dave ; Breeden, Cynthia A. ; Song, Mingqing ; Farris, Alton Brad ; Larsen, Christian P. ; Ford, Mandy L. ; Lutz, Andrew J. ; Tector, Matthew ; Newell, Kenneth A. ; Tector, A. Joseph ; Adams, Andrew B. / Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model. In: Xenotransplantation. 2015 ; Vol. 22, No. 3. pp. 221-230.
@article{f0a54b46e7ad47579865f07e3cb1f78d,
title = "Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model",
abstract = "Xenotransplantation has the potential to alleviate the organ shortage that prevents many patients with end-stage renal disease from enjoying the benefits of kidney transplantation. Despite significant advances in other models, pig-to-primate kidney xenotransplantation has met limited success. Preformed anti-pig antibodies are an important component of the xenogeneic immune response. To address this, we screened a cohort of 34 rhesus macaques for anti-pig antibody levels. We then selected animals with both low and high titers of anti-pig antibodies to proceed with kidney transplant from galactose-α1,3-galactose knockout/CD55 transgenic pig donors. All animals received T-cell depletion followed by maintenance therapy with costimulation blockade (either anti-CD154 mAb or belatacept), mycophenolate mofetil, and steroid. The animal with the high titer of anti-pig antibody rejected the kidney xenograft within the first week. Low-titer animals treated with anti-CD154 antibody, but not belatacept exhibited prolonged kidney xenograft survival (>133 and >126 vs. 14 and 21 days, respectively). Long-term surviving animals treated with the anti-CD154-based regimen continue to have normal kidney function and preserved renal architecture without evidence of rejection on biopsies sampled at day 100. This description of the longest reported survival of pig-to-non-human primate kidney xenotransplantation, now >125 days, provides promise for further study and potential clinical translation.",
keywords = "costimulation blockade, human decay-accelerating factor, non-human primate, renal transplantation, transgenic pigs, xenoantigen, xenotransplantation, α-1,3-galactosyltransferase",
author = "Laura Higginbotham and Dave Mathews and Breeden, {Cynthia A.} and Mingqing Song and Farris, {Alton Brad} and Larsen, {Christian P.} and Ford, {Mandy L.} and Lutz, {Andrew J.} and Matthew Tector and Newell, {Kenneth A.} and Tector, {A. Joseph} and Adams, {Andrew B.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1111/xen.12166",
language = "English",
volume = "22",
pages = "221--230",
journal = "Xenotransplantation",
issn = "0908-665X",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model

AU - Higginbotham, Laura

AU - Mathews, Dave

AU - Breeden, Cynthia A.

AU - Song, Mingqing

AU - Farris, Alton Brad

AU - Larsen, Christian P.

AU - Ford, Mandy L.

AU - Lutz, Andrew J.

AU - Tector, Matthew

AU - Newell, Kenneth A.

AU - Tector, A. Joseph

AU - Adams, Andrew B.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Xenotransplantation has the potential to alleviate the organ shortage that prevents many patients with end-stage renal disease from enjoying the benefits of kidney transplantation. Despite significant advances in other models, pig-to-primate kidney xenotransplantation has met limited success. Preformed anti-pig antibodies are an important component of the xenogeneic immune response. To address this, we screened a cohort of 34 rhesus macaques for anti-pig antibody levels. We then selected animals with both low and high titers of anti-pig antibodies to proceed with kidney transplant from galactose-α1,3-galactose knockout/CD55 transgenic pig donors. All animals received T-cell depletion followed by maintenance therapy with costimulation blockade (either anti-CD154 mAb or belatacept), mycophenolate mofetil, and steroid. The animal with the high titer of anti-pig antibody rejected the kidney xenograft within the first week. Low-titer animals treated with anti-CD154 antibody, but not belatacept exhibited prolonged kidney xenograft survival (>133 and >126 vs. 14 and 21 days, respectively). Long-term surviving animals treated with the anti-CD154-based regimen continue to have normal kidney function and preserved renal architecture without evidence of rejection on biopsies sampled at day 100. This description of the longest reported survival of pig-to-non-human primate kidney xenotransplantation, now >125 days, provides promise for further study and potential clinical translation.

AB - Xenotransplantation has the potential to alleviate the organ shortage that prevents many patients with end-stage renal disease from enjoying the benefits of kidney transplantation. Despite significant advances in other models, pig-to-primate kidney xenotransplantation has met limited success. Preformed anti-pig antibodies are an important component of the xenogeneic immune response. To address this, we screened a cohort of 34 rhesus macaques for anti-pig antibody levels. We then selected animals with both low and high titers of anti-pig antibodies to proceed with kidney transplant from galactose-α1,3-galactose knockout/CD55 transgenic pig donors. All animals received T-cell depletion followed by maintenance therapy with costimulation blockade (either anti-CD154 mAb or belatacept), mycophenolate mofetil, and steroid. The animal with the high titer of anti-pig antibody rejected the kidney xenograft within the first week. Low-titer animals treated with anti-CD154 antibody, but not belatacept exhibited prolonged kidney xenograft survival (>133 and >126 vs. 14 and 21 days, respectively). Long-term surviving animals treated with the anti-CD154-based regimen continue to have normal kidney function and preserved renal architecture without evidence of rejection on biopsies sampled at day 100. This description of the longest reported survival of pig-to-non-human primate kidney xenotransplantation, now >125 days, provides promise for further study and potential clinical translation.

KW - costimulation blockade

KW - human decay-accelerating factor

KW - non-human primate

KW - renal transplantation

KW - transgenic pigs

KW - xenoantigen

KW - xenotransplantation

KW - α-1,3-galactosyltransferase

UR - http://www.scopus.com/inward/record.url?scp=84930757858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930757858&partnerID=8YFLogxK

U2 - 10.1111/xen.12166

DO - 10.1111/xen.12166

M3 - Article

AN - SCOPUS:84930757858

VL - 22

SP - 221

EP - 230

JO - Xenotransplantation

JF - Xenotransplantation

SN - 0908-665X

IS - 3

ER -